Renaissance Technologies (RenTech)'s ONC Position Overview
Renaissance Technologies (RenTech) (via Renaissance Technologies LLC) currently holds 65,456 shares of BeOne Medicines AG (ONC) worth $19.44 M, representing 0.03% of the portfolio. First purchased in 2016-Q3, this medium-term investment has been held for 14 quarters.
Based on 13F filings, Renaissance Technologies (RenTech) has maintained a strategic position in ONC, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2018, adding 217,116 shares. Largest reduction occurred in Q4 2018, reducing 142,500 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies (RenTech)'s BeOne Medicines (ONC) Holding Value Over Time
Track share changes against reported price movement
Quarterly BeOne Medicines (ONC) Trades by Renaissance Technologies (RenTech)
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q1 2026 | +65,456 | New Buy | 65,456 | $296.97 |
| Q3 2023 | -9,300 | Sold Out | 0 | $0.00 |
| Q2 2023 | +9,300 | New Buy | 9,300 | $0.18 |
| Q4 2022 | -2,300 | Sold Out | 0 | $0.00 |
| Q3 2022 | +2,300 | New Buy | 2,300 | $134.78 |
| Q1 2020 | -30,619 | Sold Out | 0 | $0.00 |
| Q4 2019 | +30,619 | New Buy | 30,619 | $165.75 |
| Q4 2018 | -142,500 | Sold Out | 0 | $0.00 |
| Q3 2018 | -74,616 | Reduce 34.37% | 142,500 | $172.22 |
| Q2 2018 | +217,116 | New Buy | 217,116 | $153.73 |
| Q2 2017 | -6,500 | Sold Out | 0 | $0.00 |
| Q1 2017 | +6,500 | New Buy | 6,500 | $36.62 |
| Q4 2016 | -30,900 | Sold Out | 0 | $0.00 |
| Q3 2016 | +30,900 | New Buy | 30,900 | $30.81 |
Renaissance Technologies (RenTech)'s BeOne Medicines Investment FAQs
Renaissance Technologies (RenTech) first purchased BeOne Medicines AG (ONC) in Q3 2016, acquiring 30,900 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies (RenTech) has held BeOne Medicines AG (ONC) for 14 quarters since Q3 2016.
Renaissance Technologies (RenTech)'s largest addition to BeOne Medicines AG (ONC) was in Q2 2018, adding 217,116 shares worth $33.38 M.
According to the latest 13F filing for Q1 2026, Renaissance Technologies (RenTech)'s firm, Renaissance Technologies LLC, owns 65,456 shares of BeOne Medicines AG (ONC), valued at approximately $19.44 M.
As of the Q1 2026 filing, BeOne Medicines AG (ONC) represents approximately 0.03% of Renaissance Technologies (RenTech)'s publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies (RenTech)'s peak holding in BeOne Medicines AG (ONC) was 217,116 shares, as reported at the end of Q2 2018.